| 1 |
33454626 | Dopamine D2/3 receptor availability in cocaine use disorder individuals with obesity as measured by [11C]PHNO PET. | 2021 Mar 1 |
1 |
| 2 |
31601695 | PET Imaging of Pancreatic Dopamine D2 and D3 Receptor Density with 11C-(+)-PHNO in Type 1 Diabetes. | 2020 Apr |
2 |
| 3 |
31645049 | The Dopamine D2 Receptor Contributes to the Spheroid Formation Behavior of U87 Glioblastoma Cells. | 2020 |
2 |
| 4 |
32201327 | Separating dopamine D2 and D3 receptor sources of [11C]-(+)-PHNO binding potential: Independent component analysis of competitive binding. | 2020 Jul 1 |
1 |
| 5 |
29883636 | Expression of dopamine D2 and D3 receptors in the human retina revealed by positron emission tomography and targeted mass spectrometry. | 2018 Oct |
1 |
| 6 |
26873034 | Exploring the relationship between social attachment and dopamine D2/3 receptor availability in the brains of healthy humans using [11C]-(+)-PHNO. | 2017 Apr |
1 |
| 7 |
26141509 | Imaging the D3 dopamine receptor across behavioral and drug addictions: Positron emission tomography studies with [(11)C]-(+)-PHNO. | 2015 Sep |
1 |
| 8 |
22213512 | Affinity and selectivity of [¹¹C]-(+)-PHNO for the D3 and D2 receptors in the rhesus monkey brain in vivo. | 2012 Jun |
4 |
| 9 |
9292626 | Discriminative-stimulus effects of clozapine in squirrel monkeys: comparison with conventional and novel antipsychotic drugs. | 1997 Aug |
1 |
| 10 |
2901697 | PHNO [(+)-4-propyl-9-hydroxynaphthoxazine]: a new and effective anti-Parkinson's disease agent. | 1988 Oct |
1 |
| 11 |
2907097 | Behavioural effects of (+)-4-propyl-9-hydroxynaphthoxazine in primates rendered parkinsonian with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. | 1988 Jul |
1 |